Synergy appoints Troy Hamilton head of commercial
This article was originally published in Scrip
Synergy Pharmaceuticals has named Troy Hamilton chief commercial officer. Mr Hamilton will be responsible for Synergy’s overall commercial strategy and execution, and will implement marketing, sales, and commercial operations and infrastructure for the US launch of plecanatide, Synergy's lead gastrointestinal (GI) product. Prior to joining Synergy, he held multiple commercial leadership roles over a nine year period within Shire Pharmaceuticals' GI business unit. Most recently, he was vice-president of product strategy and commercial lead responsible for the GI motility, hepatology and pipeline products.